107 related articles for article (PubMed ID: 21054678)
21. Presence of a functional but dispensable nuclear export signal in the HTLV-2 Tax protein.
Chevalier SA; Meertens L; Calattini S; Gessain A; Kiemer L; Mahieux R
Retrovirology; 2005 Nov; 2():70. PubMed ID: 16285885
[TBL] [Abstract][Full Text] [Related]
22. Human T cell leukemia virus type 1 tax protein increases NF-kappa B dimer formation and antagonizes the inhibitory activity of the I kappa B alpha regulatory protein.
Petropoulos L; Lin R; Hiscott J
Virology; 1996 Nov; 225(1):52-64. PubMed ID: 8918533
[TBL] [Abstract][Full Text] [Related]
23. Regulatory elements involved in tax-mediated transactivation of the HTLV-I LTR.
Seeler JS; Muchardt C; Podar M; Gaynor RB
Virology; 1993 Oct; 196(2):442-50. PubMed ID: 8372429
[TBL] [Abstract][Full Text] [Related]
24. Regulation of gene expression by HTLV-I Tax protein.
Bex F; Gaynor RB
Methods; 1998 Sep; 16(1):83-94. PubMed ID: 9774518
[TBL] [Abstract][Full Text] [Related]
25. Direct trans-activation of the human cyclin D2 gene by the oncogene product Tax of human T-cell leukemia virus type I.
Huang Y; Ohtani K; Iwanaga R; Matsumura Y; Nakamura M
Oncogene; 2001 Mar; 20(9):1094-102. PubMed ID: 11314046
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of persistent NF-kappaB activation by HTLV-I tax.
Harhaj EW; Harhaj NS
IUBMB Life; 2005 Feb; 57(2):83-91. PubMed ID: 16036567
[TBL] [Abstract][Full Text] [Related]
27. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
28. Comparison of CREB- and NF-kappaB-mediated transactivation by human T lymphotropic virus type II (HTLV-II) and type I (HTLV-I) tax proteins.
Lewis MJ; Sheehy N; Salemi M; VanDamme AM; Hall WW
Virology; 2002 Mar; 295(1):182-9. PubMed ID: 12033776
[TBL] [Abstract][Full Text] [Related]
29. Ubiquitination of HTLV-I Tax in response to DNA damage regulates nuclear complex formation and nuclear export.
Gatza ML; Dayaram T; Marriott SJ
Retrovirology; 2007 Dec; 4():95. PubMed ID: 18081936
[TBL] [Abstract][Full Text] [Related]
30. Structural insights into the autoinhibition and posttranslational activation of histone methyltransferase SmyD3.
Sirinupong N; Brunzelle J; Doko E; Yang Z
J Mol Biol; 2011 Feb; 406(1):149-59. PubMed ID: 21167177
[TBL] [Abstract][Full Text] [Related]
31. SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells.
Hamamoto R; Furukawa Y; Morita M; Iimura Y; Silva FP; Li M; Yagyu R; Nakamura Y
Nat Cell Biol; 2004 Aug; 6(8):731-40. PubMed ID: 15235609
[TBL] [Abstract][Full Text] [Related]
32. Requirement of histone methyltransferase SMYD3 for estrogen receptor-mediated transcription.
Kim H; Heo K; Kim JH; Kim K; Choi J; An W
J Biol Chem; 2009 Jul; 284(30):19867-77. PubMed ID: 19509295
[TBL] [Abstract][Full Text] [Related]
33. Smyd3 open & closed lock mechanism for substrate recruitment: The hinge motion of C-terminal domain inferred from μ-second molecular dynamics simulations.
Chandramouli B; Silvestri V; Scarno M; Ottini L; Chillemi G
Biochim Biophys Acta; 2016 Jul; 1860(7):1466-74. PubMed ID: 27085704
[TBL] [Abstract][Full Text] [Related]
34. C-terminal domain of SMYD3 serves as a unique HSP90-regulated motif in oncogenesis.
Brown MA; Foreman K; Harriss J; Das C; Zhu L; Edwards M; Shaaban S; Tucker H
Oncotarget; 2015 Feb; 6(6):4005-19. PubMed ID: 25738358
[TBL] [Abstract][Full Text] [Related]
35. Cooperation between SMYD3 and PC4 drives a distinct transcriptional program in cancer cells.
Kim JM; Kim K; Schmidt T; Punj V; Tucker H; Rice JC; Ulmer TS; An W
Nucleic Acids Res; 2015 Oct; 43(18):8868-83. PubMed ID: 26350217
[TBL] [Abstract][Full Text] [Related]
36. Therapeutical potential of deregulated lysine methyltransferase SMYD3 as a safe target for novel anticancer agents.
Rajajeyabalachandran G; Kumar S; Murugesan T; Ekambaram S; Padmavathy R; Jegatheesan SK; Mullangi R; Rajagopal S
Expert Opin Ther Targets; 2017 Feb; 21(2):145-157. PubMed ID: 28019723
[TBL] [Abstract][Full Text] [Related]
37. Cell geometry and the cytoskeleton impact the nucleo-cytoplasmic localisation of the SMYD3 methyltransferase.
Pereira D; Richert A; Medjkane S; Hénon S; Weitzman JB
Sci Rep; 2020 Nov; 10(1):20598. PubMed ID: 33244033
[TBL] [Abstract][Full Text] [Related]
38. Structural and biochemical studies of human lysine methyltransferase Smyd3 reveal the important functional roles of its post-SET and TPR domains and the regulation of its activity by DNA binding.
Xu S; Wu J; Sun B; Zhong C; Ding J
Nucleic Acids Res; 2011 May; 39(10):4438-49. PubMed ID: 21266482
[TBL] [Abstract][Full Text] [Related]
39. SMYD3-mediated lysine methylation in the PH domain is critical for activation of AKT1.
Yoshioka Y; Suzuki T; Matsuo Y; Nakakido M; Tsurita G; Simone C; Watanabe T; Dohmae N; Nakamura Y; Hamamoto R
Oncotarget; 2016 Nov; 7(46):75023-75037. PubMed ID: 27626683
[TBL] [Abstract][Full Text] [Related]
40. SMYD3-Mediated H2A.Z.1 Methylation Promotes Cell Cycle and Cancer Proliferation.
Tsai CH; Chen YJ; Yu CJ; Tzeng SR; Wu IC; Kuo WH; Lin MC; Chan NL; Wu KJ; Teng SC
Cancer Res; 2016 Oct; 76(20):6043-6053. PubMed ID: 27569210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
